Human growth hormone to stimulate hematopoiesis and immune constitution after transplantation with human hematopoietic stem cells

摘要

The invention relates to the use of human growth hormone for the manufacture of a medicament for stimulating hematopoiesis and immune reconstitution to be administered to a patient in need thereof about 30 days post-transplantation of hematopoietic stem cells.